William Stratton


Will Stratton joined Avalon portfolio company Avelas Biosciences in 2019 as the Head of Business Development. Mr. Stratton previously led early-stage global business development at Rakuten Medical. Prior to Rakuten Medical, Mr. Stratton held roles in business development, corporate strategy, and commercial planning at NAVICAN Genomics and Cidara Therapeutics. Mr. Stratton started his career in life sciences consulting, where he advised clients in the areas of business development and commercial strategy. Mr. Stratton received an MBA with concentrations in Healthcare Management and Entrepreneurial Management from The Wharton School at the University of Pennsylvania and a B.S. in Chemistry from Yale University.

Avalon Bioventures